首页>
外国专利>
Cancer therapeutic agent using IL-18 and molecular target antibody in combination
Cancer therapeutic agent using IL-18 and molecular target antibody in combination
展开▼
机译:结合使用IL-18和分子靶标抗体的癌症治疗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The cancer therapeutic agent according to the present invention includes IL-18 and anti-PD-L1 antibody, anti-PD-1 antibody, anti-PD-L2 antibody, anti-CTLA-4 antibody, anti-CD25 antibody, anti-CD33 antibody and anti-CD52 antibody. One or more antibodies selected from the group consisting of:
展开▼